Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 02/02/2001, Revision: 24, Status: Authorised

2019 ◽  
Author(s):  
Sign in / Sign up

Export Citation Format

Share Document